Marinus Pharmaceuticals Q3 EPS $(0.26) Up From $(0.27) YoY

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly losses of $(0.26) per share. This is a 3.7 percent increase over losses of $(0.27) per share from the same period last year.

Benzinga · 11/06/2019 12:48

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly losses of $(0.26) per share. This is a 3.7 percent increase over losses of $(0.27) per share from the same period last year.